Vascular Biogenics: The IPO That Wasn't

The Wall Street Journal
August 12, 2014 AT 10:38 AM
It was the IPO that wasn't: A biotech firm hit the market and traded for six days, only to announce Friday that it wasn't issuing shares after all, thanks to a key investor's failure to follow through on a commitment to buy stock. Dan Strumpf joins MoneyBeat with Paul Vigna.